Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -7.86% is 93% above its 5-year average of -116.74%, near the high end of its 5-year range (-5941.67%–27.49%).
23.58% above its 12-month average of -10.29%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10.28%.
OPERATING MARGIN
-7.86%
OPERATING MARGIN AVG TTM
-10.29%
OPERATING MARGIN AVG 3Y
-23.55%
OPERATING MARGIN AVG 5Y
-116.74%
OPERATING MARGIN AVG 10Y
-304.59%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+23.58%
CURRENT VS 3Y AVG
+66.63%
CURRENT VS 5Y AVG
+93.27%
CURRENT VS 10Y AVG
+97.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ardelyx, Inc.
Market Cap
$817.67M
Operating Margin
-7.86%
TTM Avg
-10.29%
3Y Avg
-23.55%
5Y Avg
-116.74%
Market Cap
$816.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$828.48M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$833.81M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
Market Cap
$838.16M
Operating Margin
-69.75%
TTM Avg
-70.49%
3Y Avg
-9306.05%
5Y Avg
-9306.05%
Market Cap
$838.62M
Operating Margin
-348.46%
TTM Avg
-328.22%
3Y Avg
-265.67%
5Y Avg
-226.03%
Market Cap
$789.34M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
Market Cap
$785.03M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $817.67M | -7.86% | -10.29% | -23.55% | -116.74% |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMode Ltd. (INMD)vs › | $804.16M | 18.47% | 25.77% | 33.72% | 36.17% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | -43.83% | -75.55% | -37.77% | -25.18% |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | -69.75% | -70.49% | -9306.05% | -9306.05% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | -348.46% | -328.22% | -265.67% | -226.03% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | 9.86% | 12.61% | -6.26% | -239.99% |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | -0.31% | 6.92% | 0.39% | 2.91% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -174.65% | -105.11% | -66.40% | -66.40% |
Gross Margin
94.0%
Operating Margin
-7.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -10.28% |
| 2026-03-31 | -34.71% |
| 2025-12-31 | 4.07% |
| 2025-09-30 | 4.23% |
| 2025-06-30 | -14.74% |
| 2025-03-31 | -49.04% |
| 2024-12-31 | 7.00% |
| 2024-09-30 | 2.27% |
| 2024-06-30 | -18.61% |
| 2024-03-31 | -53.62% |
| 2023-12-31 | -81.44% |
| 2023-09-30 | 13.12% |
| 2023-06-30 | -74.44% |
| 2023-03-31 | -229.25% |
| 2022-12-31 | 27.49% |
| 2022-09-30 | -438.83% |
| 2022-06-30 | -1037.81% |
| 2022-03-31 | -5941.67% |
| 2021-12-31 | -3427.89% |
| 2021-09-30 | -3600.68% |
| 2021-06-30 | -3414.47% |
| 2021-03-31 | -486.25% |
| 2020-12-31 | -1528.08% |
| 2020-09-30 | -632.55% |
| 2020-06-30 | -1318.46% |
| 2020-03-31 | -1794.64% |
| 2019-12-31 | -837.69% |
| 2019-09-30 | -733.12% |
| 2019-06-30 | -137933.33% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | -32207.06% |
| 2018-09-30 | -13797.67% |
| 2018-06-30 | -73846.67% |
| 2018-03-31 | -762.28% |
| 2017-12-31 | 26.10% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 49.91% |
| 2015-03-31 | -59.32% |
| 2014-12-31 | -62.04% |
| 2014-09-30 | 1.07% |
| 2014-06-30 | 30.11% |
| 2014-03-31 | -5.43% |
| 2013-12-31 | -8.46% |
| 2013-09-30 | -13.44% |
| 2013-06-30 | -11.67% |
| 2013-03-31 | -6.25% |
